Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear Cell Ovarian Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03602586
What this trial is testing

Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer

Who this might be right for
Malignant Ovarian Clear Cell TumorRecurrent Ovarian Carcinoma
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Early research (Phase 1)Study completedNCT03297424
What this trial is testing

PLX2853 in Advanced Malignancies.

Who this might be right for
Small Cell Lung CancerUveal MelanomaOvarian Clear Cell Carcinoma+5 more
Opna Bio LLC 49
Very early researchStudy completedNCT02111941
What this trial is testing

Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid TumorFallopian Tube Mucinous Neoplasm+20 more
Mayo Clinic 19
Large-scale testing (Phase 3)Active Not RecruitingNCT02446600
What this trial is testing

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Transitional Cell CarcinomaFallopian Tube Undifferentiated Carcinoma+10 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06639074
What this trial is testing

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Fallopian Tube High Grade Serous AdenocarcinomaAdvanced Ovarian Carcinoma+15 more
Mayo Clinic 78
Not applicableWithdrawnNCT00499291
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT05032040
What this trial is testing

XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Who this might be right for
Ovarian CancerClear Cell CarcinomaEndometrial Cancer+2 more
Xencor, Inc. 170
Not applicableEnded earlyNCT00899093
What this trial is testing

YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy

Who this might be right for
Fallopian Tube AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+27 more
Gynecologic Oncology Group 2,500
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Early research (Phase 1)Study completedNCT00006235
What this trial is testing

Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT02520115
What this trial is testing

Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer

Who this might be right for
Adnexal MassBorderline Ovarian Epithelial TumorOvarian Clear Cell Tumor+4 more
Barbara Ann Karmanos Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT00466960
What this trial is testing

Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+9 more
University of Washington 21
Early research (Phase 1)Study completedNCT04148937
What this trial is testing

The CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 52
Testing effectiveness (Phase 2)Study completedNCT01935934
What this trial is testing

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT03348631
What this trial is testing

Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer

Who this might be right for
Recurrent Endometrial Endometrioid AdenocarcinomaRecurrent Malignant Uterine Corpus NeoplasmRecurrent Ovarian Carcinoma+2 more
National Cancer Institute (NCI) 62
Early research (Phase 1)UnknownNCT05498597
What this trial is testing

AMT-151 in Patients With Selected Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorAdvanced CancerAdvanced Carcinoma+16 more
Multitude Therapeutics Inc. 30
Large-scale testing (Phase 3)Study completedNCT00951496
What this trial is testing

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+35 more
National Cancer Institute (NCI) 1,560
Not applicableEnded earlyNCT01275664
What this trial is testing

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

Who this might be right for
Nausea and VomitingOvarian Brenner TumorOvarian Clear Cell Cystadenocarcinoma+24 more
Gynecologic Oncology Group 4
Not applicableUnknownNCT06237946
What this trial is testing

Early-stage Ovarian Clear Cell Carcinoma (OCCC) Patients at Risk of Recurrence

Who this might be right for
FIGO Stage IC2 to II Ovarian Clear Cell Carcinoma
National Taiwan University Hospital 272
Next Page
579